Arcus Biosciences, Inc. SEC filings RCUS

Arcus Biosciences, Inc. has 609 filings in SEC EDGAR's recent list, going back to Dec 15, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Arcus Biosciences, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Other events
Oct 23, 2026 Oct 21, 2026
424B5 Prospectus supplement Oct 22, 2026 —
424B5 Prospectus supplement Oct 21, 2026 —
8-K Current report
Results of operations
Oct 21, 2026 Oct 21, 2026
8-K Current report
Other events
Oct 20, 2026 Oct 20, 2026
CT ORDER Filing Sep 28, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 11, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
ARS Annual report to shareholders Apr 21, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 21, 2026 —
DEF 14A Proxy statement Apr 21, 2026 Jun 11, 2026
8-K Current report
Other events
Apr 20, 2026 Apr 20, 2026
8-K Current report
Officer or director change
Mar 23, 2026 Mar 17, 2026
S-3ASR Automatic shelf registration Feb 25, 2026 —
S-8 Employee stock plan registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
8-K Current report
Material agreement, New debt
Dec 18, 2025 Dec 18, 2025
8-K Current report
Other events
Dec 12, 2025 Dec 12, 2025
8-K Current report
Other events
Nov 3, 2025 Oct 30, 2025
424B5 Prospectus supplement Oct 31, 2025 —
424B5 Prospectus supplement Oct 30, 2025 —
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
8-K Current report
Other events
Oct 14, 2025 Oct 12, 2025
8-K Current report
Other events
Oct 6, 2025 Oct 6, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Shareholder vote results, Other events
Jun 12, 2025 Jun 10, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2025 Jun 1, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 22, 2025 —
DEF 14A Proxy statement Apr 22, 2025 Jun 10, 2025
S-8 Employee stock plan registration Feb 25, 2025 —
10-K Annual report Feb 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 25, 2025 Feb 25, 2025
8-K Current report
Other events
Feb 19, 2025 Feb 18, 2025
424B5 Prospectus supplement Feb 18, 2025 —
8-K Current report
Results of operations, Other events
Feb 18, 2025 Feb 15, 2025
8-K Current report
Officer or director change
Feb 6, 2025 Feb 6, 2025
8-K Current report
Officer or director change
Jan 21, 2025 Jan 16, 2025
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 24, 2024 Oct 24, 2024
8-K Current report
Material agreement, New debt
Aug 27, 2024 Aug 27, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results, Other events
Jun 6, 2024 Jun 6, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2024 Jun 2, 2024
8-K Current report
Other events
May 23, 2024 May 23, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Jun 6, 2024
S-3ASR Automatic shelf registration Feb 21, 2024 —
S-8 Employee stock plan registration Feb 21, 2024 —
10-K Annual report Feb 21, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 21, 2024 Feb 21, 2024
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Jan 30, 2024 Jan 29, 2024
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 7, 2023 Aug 7, 2023
8-K Current report
Material agreement, Unregistered share sale
Jun 28, 2023 Jun 27, 2023
8-K Current report
Shareholder vote results, Other events
Jun 16, 2023 Jun 15, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 5, 2023 Jun 3, 2023
8-K Current report
Material agreement
May 15, 2023 May 15, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
ARS Annual report to shareholders Apr 25, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 21, 2023 —
DEF 14A Proxy statement Apr 21, 2023 —
8-K Current report
Officer or director change
Mar 10, 2023 Mar 9, 2023
S-3ASR Automatic shelf registration Feb 28, 2023 —
S-8 Employee stock plan registration Feb 28, 2023 —
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Other events
Dec 19, 2022 Dec 19, 2022
8-K Current report
Other events
Nov 28, 2022 Nov 28, 2022
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 2, 2022 Nov 2, 2022
S-3ASR Automatic shelf registration Oct 11, 2022 —
8-K Current report
Material agreement
Oct 11, 2022 Oct 11, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Shareholder vote results, Other events
Jun 16, 2022 Jun 14, 2022
UPLOAD Letter from the SEC Jun 7, 2022 —
CORRESP Letter to the SEC Jun 3, 2022 —
UPLOAD Letter from the SEC May 10, 2022 —
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
DEFA14A Additional proxy material Apr 20, 2022 —
DEF 14A Proxy statement Apr 20, 2022 Jun 14, 2022
S-8 Employee stock plan registration Feb 23, 2022 —
10-K Annual report Feb 23, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 23, 2022 Feb 23, 2022
8-K Current report
Other events
Dec 21, 2021 Dec 21, 2021
8-K Current report
Material agreement
Nov 18, 2021 Nov 17, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
10-Q Quarterly report Nov 8, 2021 Sep 30, 2021
8-K Current report
Officer or director change
Aug 11, 2021 Aug 10, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations, Officer or director change
Aug 5, 2021 Aug 3, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 19, 2021 Jul 16, 2021
8-K Current report
Shareholder vote results, Other events
Jun 7, 2021 Jun 3, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
8-K Current report
Regulation FD disclosure
Apr 26, 2021 Apr 23, 2021
DEFA14A Additional proxy material Apr 20, 2021 —
DEF 14A Proxy statement Apr 20, 2021 Jun 3, 2021
8-K Current report
Listing notice
Apr 19, 2021 Apr 16, 2021
8-K Current report
Other events
Mar 16, 2021 Mar 16, 2021
S-8 Employee stock plan registration Feb 25, 2021 —
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
8-K Current report
Material agreement, Unregistered share sale
Feb 1, 2021 Jan 31, 2021
8-K Current report
Officer or director change
Jan 6, 2021 Jan 6, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 18, 2020 Dec 17, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change
Oct 1, 2020 Oct 1, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Officer or director change, Other events
Jul 13, 2020 Jul 13, 2020
8-K Current report
Officer or director change
Jul 7, 2020 Jul 7, 2020
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2020 Jun 4, 2020
8-K Current report
Other events
May 29, 2020 May 28, 2020
424B5 Prospectus supplement May 29, 2020 —
424B5 Prospectus supplement May 28, 2020 —
S-3ASR Automatic shelf registration May 27, 2020 —
8-K Current report
Material agreement, Unregistered share sale
May 27, 2020 May 27, 2020
DEFA14A Additional proxy material May 26, 2020 —
8-K Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
May 26, 2020 May 21, 2020
10-Q Quarterly report May 5, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 5, 2020 May 5, 2020
DEFA14A Additional proxy material Apr 21, 2020 —
DEF 14A Proxy statement Apr 21, 2020 Jun 4, 2020
8-K Current report
Regulation FD disclosure
Apr 7, 2020 Apr 7, 2020
S-8 Employee stock plan registration Mar 5, 2020 —
10-K Annual report Mar 5, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 5, 2020 Mar 5, 2020
8-K Current report
Officer or director change
Dec 12, 2019 Dec 10, 2019
8-K/A Amended current report
Officer or director change
Nov 25, 2019 Sep 10, 2019
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
8-K Current report
Officer or director change
Oct 28, 2019 Oct 28, 2019
8-K Current report
Officer or director change
Sep 16, 2019 Sep 16, 2019
8-K Current report
Officer or director change
Sep 3, 2019 Sep 3, 2019
10-Q Quarterly report Aug 6, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
8-K Current report
Shareholder vote results
Jun 7, 2019 Jun 6, 2019
DEFA14A Additional proxy material May 28, 2019 —
10-Q Quarterly report May 2, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 2, 2019 May 2, 2019
424B5 Prospectus supplement Apr 26, 2019 —
EFFECT Filing Apr 25, 2019 —
CORRESP Letter to the SEC Apr 23, 2019 —
DEFA14A Additional proxy material Apr 22, 2019 —
DEF 14A Proxy statement Apr 22, 2019 Jun 6, 2019
S-3 Shelf registration Apr 2, 2019 —
8-K/A Amended current report
Officer or director change
Mar 29, 2019 Mar 25, 2019
8-K Current report
Results of operations
Mar 25, 2019 Mar 25, 2019
S-8 Employee stock plan registration Mar 5, 2019 —
10-K Annual report Mar 5, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 5, 2019 Mar 5, 2019
8-K Current report
Officer or director change
Jan 4, 2019 Dec 31, 2018
CT ORDER Filing Nov 16, 2018 —
10-Q Quarterly report Nov 8, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 8, 2018 Sep 30, 2018
8-K Current report
Officer or director change
Oct 22, 2018 Oct 19, 2018
10-Q Quarterly report Aug 6, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 6, 2018 Jun 30, 2018
8-K Current report
Other events
Jul 12, 2018 Jul 12, 2018
8-K Current report
Officer or director change
Jun 12, 2018 Jun 8, 2018
10-Q Quarterly report May 9, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 9, 2018 May 9, 2018
S-8 Employee stock plan registration Mar 16, 2018 —
424B4 Prospectus Mar 16, 2018 —
CT ORDER Filing Mar 15, 2018 —
UPLOAD Letter from the SEC Mar 15, 2018 —
EFFECT Filing Mar 14, 2018 —
S-1MEF Filing Mar 14, 2018 —
CORRESP Letter to the SEC Mar 12, 2018 —
CORRESP Letter to the SEC Mar 12, 2018 —
CERT Nyse cert- arcus biosciences, inc. Mar 12, 2018 —
8-A12B Form 8-a12b Mar 9, 2018 —
S-1/A Amended registration statement Mar 9, 2018 —
CORRESP Letter to the SEC Mar 5, 2018 —
S-1/A Amended registration statement Mar 5, 2018 —
CORRESP Letter to the SEC Feb 20, 2018 —
CORRESP Letter to the SEC Feb 16, 2018 —
S-1 Registration statement Feb 16, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RCUS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hayward, CA
SEC filer status
Large accelerated filer
SEC CIK
1724521

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.